PRESS RELEASE published on 07/17/2026 at 18:00, 3 months 19 days ago ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 30.06.26 ABIVAX publie les nombres d'actions et de droits de vote au 30/06/26 conformément aux réglementations AMF. La société se concentre sur le développement de traitements pour les maladies inflammatoires Droits De Vote Actions Abivax Réglementation Traitements
BRIEF published on 07/06/2026 at 22:10, 3 months 30 days ago Abivax Achève son Offre Publique de 920 Millions de Dollars Biotechnologie Actions Financement Abivax Offre Publique
BRIEF published on 07/06/2026 at 22:10, 3 months 30 days ago Abivax Completes its $920 Million Public Offering Biotechnology Actions Funding Abivax Public Offering
BRIEF published on 07/06/2026 at 22:10, 3 months 30 days ago Abivax Secures $920 Million in Public Offering Biotechnology Abivax Ulcerative Colitis Public Offering American Depositary Shares
BRIEF published on 07/06/2026 at 22:10, 3 months 30 days ago Abivax lève 920 millions de dollars lors d'une offre publique Biotechnologie Abivax Rectocolite Hémorragique Offre Publique Actions De Dépôt Américaines
PRESS RELEASE published on 07/06/2026 at 22:05, 3 months 30 days ago Abivax annonce la réalisation de son offre au public de 920 millions de dollars Abivax réalise son offre publique de 920 millions de dollars pour le développement de thérapies biotechnologiques. Les actions sont cotées sur Euronext Paris et le Nasdaq Biotechnologie Abivax Offre Publique Thérapies Cotées
PRESS RELEASE published on 07/06/2026 at 22:05, 3 months 30 days ago Abivax annonce la réalisation de son offre au public de 920 millions de dollars Abivax annonce la réalisation de son offre au public de 920 millions de dollars. La société de biotechnologie lève des fonds pour ses thérapies contre les maladies inflammatoires Biotechnologie Abivax Offre Publique Maladies Inflammatoires Millions De Dollars
PRESS RELEASE published on 07/06/2026 at 22:05, 3 months 30 days ago Abivax Announces Closing of $920 Million Public Offering Abivax closes $920 million public offering, strengthening financial position. Proceeds to support operations until Q4 2029. Leerink Partners, Morgan Stanley, Piper Sandler, Guggenheim Securities involved in the offering Financial Position Abivax Morgan Stanley Public Offering Leerink Partners
BRIEF published on 07/02/2026 at 08:05, 4 months 3 days ago Abivax conclut une offre d'ADS avec succès Biotechnologie Abivax Investissements Ads Offre
BRIEF published on 07/02/2026 at 08:05, 4 months 3 days ago Abivax successfully concludes an ADS offer Biotechnology Abivax Offer Ads Investments
Published on 11/06/2026 at 00:53, 1 hour 14 minutes ago Sekur Private Data Engages Darkstar Capital for Investor Awareness and Sekur Product Distribution
Published on 11/06/2026 at 00:45, 1 hour 22 minutes ago Gabriel Announces Closure of ICSID Annulment Proceedings
Published on 11/05/2026 at 23:55, 2 hours 12 minutes ago Santé Canada autorise deux vaccins à ARNm de Moderna : un vaccin contre la grippe et un vaccin combiné contre la grippe et la COVID-19
Published on 11/05/2026 at 23:20, 2 hours 47 minutes ago Health Canada Authorizes Moderna's mRNA Influenza and Combination Influenza and COVID-19 Vaccines
Published on 11/06/2026 at 00:05, 2 hours 2 minutes ago RBI: Announcement of the result of the voluntary public tender offer for all Addiko shares following expiration of the grace period
Published on 11/05/2026 at 22:05, 4 hours 2 minutes ago Quantinuum Reports Third Quarter 2026 Results and Raises Full-Year Revenue Outlook
Published on 11/05/2026 at 20:38, 5 hours 29 minutes ago freenet uses funds from Ceconomy sale for waipu.tv acquisition and share buyback
Published on 11/05/2026 at 20:37, 5 hours 30 minutes ago EQS-Adhoc: freenet AG decides on share buyback programme for up to EUR 75 million
Published on 11/05/2026 at 19:45, 6 hours 21 minutes ago Stabilus SE fulfills forecast for fiscal 2026 and adjusts 2030 medium-term targets
Published on 11/05/2026 at 18:21, 7 hours 45 minutes ago Capital et droits de vote au 31 octobre 2026
Published on 11/05/2026 at 18:21, 7 hours 45 minutes ago Total number of voting rights and shares making up the share capital at October 31, 2026
